Humana Inc.’s stock price takes a dive, plummeting 10.20% to a sobering $233.89

Humana Inc. (HUM)

233.89 USD -26.57 (-10.20%) Volume: 5.61M

Humana Inc.’s stock price stands at 233.89 USD, witnessing a significant drop of 10.20% in the latest trading session with a volume of 5.61M, reflecting a substantial year-to-date decrease of 48.91%, indicating a turbulent year for HUM investors.

Latest developments on Humana Inc.

Humana Inc. stock price experienced a 6.1% decrease today, reaffirming a neutral rating due to earnings risks. The company faces challenges as its stock star ratings are impacted by a leadership transition, according to a recent SWOT analysis. Shareholders who invested in Humana a year ago are currently in the red. Despite this, Wilmington Savings Fund Society FSB has recently purchased a new position in Humana Inc., indicating potential confidence in the company’s future performance.

Humana Inc. on Smartkarma

Analysts on Smartkarma, such as Baptista Research, are closely following Humana Inc, a key player in the U.S. health insurance market. According to Baptista Research, Humana could potentially be the next major acquisition target for Cigna, one of its competitors. Recent reports suggest that informal talks between Cigna and Humana have resumed after previously falling apart. This news comes at a time when Humana is facing challenges due to changes in the government’s Medicare plan ratings impacting its performance.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has received positive scores in Value and Dividend, indicating a favorable long-term outlook for the company. With a strong focus on providing managed health care services to its members in the United States and Puerto Rico, Humana’s Value and Dividend scores suggest that the company is financially stable and offers attractive returns for investors. Additionally, the company’s Growth, Resilience, and Momentum scores, while slightly lower, still indicate a solid overall outlook for Humana Inc.

As a managed health care company, Humana Inc. offers a variety of health care options to employer groups, government-sponsored plans, and individuals. With a focus on coordinated health care through different plans and products, Humana aims to provide quality services to its medical members. The company’s strong Value and Dividend scores, along with its moderate scores in Growth, Resilience, and Momentum, suggest that Humana Inc. is well-positioned for long-term success in the managed health care industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma